Literature DB >> 27218012

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Lisa B VanWagner1, Mary E Rinella2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide with an increased prevalence of metabolic, macro- and microvascular complications. The primary causes of mortality in NAFLD are cardiovascular disease (CVD), malignancy and liver disease. NAFLD is a multisystem disease that affects a variety of extra-hepatic organ systems. The main focus of this review is to summarize the reported extra-hepatic associations, which include CVD, chronic kidney disease, obstructive sleep apnea, osteoporosis, psoriasis, colorectal cancer, iron overload and various endocrinopathies (e.g. type 2 diabetes mellitus, thyroid dysfunction, and polycystic ovarian syndrome). Due to the systemic manifestations of NAFLD patients require a multidisciplinary assessment and may benefit from more rigorous surveillance and early treatment interventions to decrease mortality related to malignancy or cardiometabolic diseases.

Entities:  

Keywords:  bone disease; cardiovascular disease (CVD); diabetes; iron overload; kidney disease; nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); sex hormones; sleep apnea; thyroid disease

Year:  2016        PMID: 27218012      PMCID: PMC4874648          DOI: 10.1007/s11901-016-0295-9

Source DB:  PubMed          Journal:  Curr Hepatol Rep        ISSN: 2195-9595


  115 in total

1.  Serum gamma-glutamyl transferase and risk of heart failure in the community.

Authors:  Ravi Dhingra; Philimon Gona; Thomas J Wang; Caroline S Fox; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

2.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Kris V Kowdley; Patricia Belt; Laura A Wilson; Matthew M Yeh; Brent A Neuschwander-Tetri; Naga Chalasani; Arun J Sanyal; James E Nelson
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

3.  Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.

Authors:  Kathleen E Corey; Joseph Misdraji; Lou Gelrud; Lindsay Y King; Hui Zheng; Atul Malhotra; Raymond T Chung
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

4.  Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.

Authors:  Goh Eun Chung; Donghee Kim; Won Kim; Jeong Yoon Yim; Min Jung Park; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee
Journal:  J Hepatol       Date:  2012-03-14       Impact factor: 25.083

Review 5.  Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease.

Authors:  Giovanni Musso; Maurizio Cassader; Solomon Cohney; Silvia Pinach; Francesca Saba; Roberto Gambino
Journal:  Trends Mol Med       Date:  2015-10       Impact factor: 11.951

6.  The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.

Authors:  K K Roberts; A E Cochet; P B Lamb; P J Brown; D F Battafarano; E M Brunt; S A Harrison
Journal:  Aliment Pharmacol Ther       Date:  2014-12-18       Impact factor: 8.171

Review 7.  The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.

Authors:  Raxitkumar Jinjuvadia; Prateek Lohia; Chetna Jinjuvadia; Sergio Montoya; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2013-01       Impact factor: 3.062

8.  Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease.

Authors:  Julia L Newton; Jessie Pairman; Katharine Wilton; David E J Jones; Christopher Day
Journal:  Clin Auton Res       Date:  2009-12       Impact factor: 4.435

9.  Chronic intermittent hypoxia predisposes to liver injury.

Authors:  Vladimir Savransky; Ashika Nanayakkara; Angelica Vivero; Jianguo Li; Shannon Bevans; Philip L Smith; Michael S Torbenson; Vsevolod Y Polotsky
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

Review 10.  Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Giovanni Musso; Roberto Gambino; James H Tabibian; Mattias Ekstedt; Stergios Kechagias; Masahide Hamaguchi; Rolf Hultcrantz; Hannes Hagström; Seung Kew Yoon; Phunchai Charatcharoenwitthaya; Jacob George; Francisco Barrera; Svanhildur Hafliðadóttir; Einar Stefan Björnsson; Matthew J Armstrong; Laurence J Hopkins; Xin Gao; Sven Francque; An Verrijken; Yusuf Yilmaz; Keith D Lindor; Michael Charlton; Robin Haring; Markus M Lerch; Rainer Rettig; Henry Völzke; Seungho Ryu; Guolin Li; Linda L Wong; Mariana Machado; Helena Cortez-Pinto; Kohichiroh Yasui; Maurizio Cassader
Journal:  PLoS Med       Date:  2014-07-22       Impact factor: 11.069

View more
  32 in total

Review 1.  Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?

Authors:  Margaret Spinosa; Jonathan G Stine
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

Review 2.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

Review 3.  Optimizing patients with non-alcoholic fatty liver disease pre-transplant.

Authors:  Amine Benmassaoud; Marc Deschenes; Tianyan Chen; Peter Ghali; Giada Sebastiani
Journal:  Can Liver J       Date:  2020-08-20

4.  Trimming the fat in non-alcoholic fatty liver disease management.

Authors:  Sanjeev Sirpal; Eric M Yoshida; Natasha Chandok
Journal:  Can Liver J       Date:  2019-08-27

5.  The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.

Authors:  S H Ahn; D H Seo; S H Kim; M-S Nam; S Hong
Journal:  Osteoporos Int       Date:  2017-10-19       Impact factor: 4.507

6.  New insights into NAFLD and subclinical coronary atherosclerosis.

Authors:  Lisa B VanWagner
Journal:  J Hepatol       Date:  2018-02-17       Impact factor: 25.083

7.  Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease.

Authors:  Harpal S Dhaliwal; Ripudaman Singh; Abin M Abraham; Rajan Sharma; N K Goyal; Rajat Soloman; Pankaj Bansal; Amandeep Goyal
Journal:  Dig Dis Sci       Date:  2021-01-06       Impact factor: 3.199

8.  Hepatic Steatosis: An Incidental Finding That Deserves Attention.

Authors:  Amy V Kontrick; Lisa B VanWagner; Chen Yeh; D Mark Courtney
Journal:  Acad Emerg Med       Date:  2020-12-15       Impact factor: 3.451

9.  The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study.

Authors:  Laura S Chiu; Alison Pedley; Joseph M Massaro; Emelia J Benjamin; Gary F Mitchell; David D McManus; Jayashri Aragam; Ramachandran S Vasan; Susan Cheng; Michelle T Long
Journal:  Liver Int       Date:  2020-07-25       Impact factor: 5.828

10.  The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Shelley E Harris; Toryn M Poolman; Anastasia Arvaniti; Roger D Cox; Laura L Gathercole; Jeremy W Tomlinson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-08-05       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.